Printer friendly version Share


MEDIA ALERT - Stop discriminating against cancer survivors

01 March 2018 — 02 February 2018 European Organisation for Research and Treatment of Cancer (EORTC)

WHAT: European Organisation for Research and Treatment of Cancer (EORTC) will host the 3rd EORTC Cancer Survivorship Summit, in Brussels Belgium on 1 - 2 March 2018. At the Summit, EORTC will raise awareness on the discrimination of cancer survivors by presenting the latest findings on medical and societal issues, published in a special issue of the Journal of Cancer Policy.

WHO: Insurers, policy makers, clinicians, researchers, former and current cancer patients will convene at the Summit to discuss the issues that cancer survivors face with the view of changing health policy to protect the rights of these people.

EVENT: Press Conference to be held on 1 March 2018 at 12:30 PM.

WHERE: Radisson Blu Royal Hotel, 47 rue du Fossé-aux-Loups, 1000 Brussels, Belgium

WHY: Over 50% of cancer patients survive their disease beyond five years and, in some cases, it is over 80%. The cancer survival rates in Europe have been steadily increasing and it is estimated that there are more than 10 million cancer survivors in Europe today. However, many cancer survivors suffer and may struggle to resume normal life. Many cancer survivors find returning to work very difficult, as they are physically unable to return to their jobs and are discriminated against by employers who are fearful of reintegrating them back into their companies. Obtaining health insurance or other financial services is extremely difficult and expensive.

In addition, some survivors have long-term medical side effects, such as chronic fatigue, infertility and psychological disorders; healthcare providers must address these new issues. It is time to stop discriminating against cancer survivors and support them to resume their normal life. For more information about the event, go to the Summit website.

ABOUT: European Organisation for Research and Treatment of Cancer conducts clinical research in cancer, defining new standards of practice for better treatment and care of cancer patients. EORTC network comprises more than 5500 multidisciplinary collaborators in more than 830 hospitals and institutions in 35 countries. For more information, visit

New Cambridge millet TON logo WCSJ-2019 expertsvar 2015 New Norwegian logo FNSF ad